These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21094254)

  • 1. Relevance of equivalence assessment of topical products based on the dermatopharmacokinetics approach.
    Boix-Montanes A
    Eur J Pharm Sci; 2011 Feb; 42(3):173-9. PubMed ID: 21094254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in methodologies for evaluating bioequivalence of topical formulations.
    Shah VP
    Am J Clin Dermatol; 2001; 2(5):275-80. PubMed ID: 11721645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.
    Raney SG; Franz TJ; Lehman PA; Lionberger R; Chen ML
    Clin Pharmacokinet; 2015 Nov; 54(11):1095-106. PubMed ID: 26063051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical microdialysis in skin and soft tissues: an update.
    Schmidt S; Banks R; Kumar V; Rand KH; Derendorf H
    J Clin Pharmacol; 2008 Mar; 48(3):351-64. PubMed ID: 18285620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics.
    N'Dri-Stempfer B; Navidi WC; Guy RH; Bunge AL
    Pharm Res; 2009 Feb; 26(2):316-28. PubMed ID: 18941872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration.
    Lodén M; Akerström U; Lindahl K; Berne B
    Int J Pharm; 2004 Oct; 284(1-2):23-30. PubMed ID: 15454293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
    Mamidi RN; Weng S; Stellar S; Wang C; Yu N; Huang T; Tonelli AP; Kelley MF; Angiuoli A; Fung MC
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1173-84. PubMed ID: 20661737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
    Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
    Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tape stripping procedure--evaluation of some critical parameters.
    Lademann J; Jacobi U; Surber C; Weigmann HJ; Fluhr JW
    Eur J Pharm Biopharm; 2009 Jun; 72(2):317-23. PubMed ID: 18775778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
    Wiedersberg S; Naik A; Leopold CS; Guy RH
    Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current challenges in bioequivalence, quality, and novel assessment technologies for topical products.
    Yacobi A; Shah VP; Bashaw ED; Benfeldt E; Davit B; Ganes D; Ghosh T; Kanfer I; Kasting GB; Katz L; Lionberger R; Lu GW; Maibach HI; Pershing LK; Rackley RJ; Raw A; Shukla CG; Thakker K; Wagner N; Zovko E; Lane ME
    Pharm Res; 2014 Apr; 31(4):837-46. PubMed ID: 24395404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modeling.
    Singh GJ; Adams WP; Lesko LJ; Shah VP; Molzon JA; Williams RL; Pershing LK
    Clin Pharmacol Ther; 1999 Oct; 66(4):346-57. PubMed ID: 10546918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Clobetasol Propionate Generics Using Simplified In vitro Bioequivalence Method for Topical Drug Products.
    Soares KCC; de Souza WC; de S Texeira L; da Cunha-Filho MSS; Gelfuso GM; Gratieri T
    Curr Drug Deliv; 2018; 15(7):998-1008. PubMed ID: 29165079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method.
    Benfeldt E; Hansen SH; Vølund A; Menné T; Shah VP
    J Invest Dermatol; 2007 Jan; 127(1):170-8. PubMed ID: 16874309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of international regulatory bioequivalence recommendations for approval of generic topical dermatological drug products.
    Braddy AC; Davit BM; Stier EM; Conner DP
    AAPS J; 2015 Jan; 17(1):121-33. PubMed ID: 25344440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.